Logo image of DRUG

BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Analyst Earnings Estimates

NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD

37.65  +0.4 (+1.07%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023
Revenue
YoY % growth
DRUG revenue by date.DRUG revenue by date.
EBITDA
YoY % growth
DRUG ebitda by date.DRUG ebitda by date.
N/AN/AN/A-14.967M-7.294M
51.26%
EBIT
YoY % growth
DRUG ebit by date.DRUG ebit by date.
-78.72K-480.38K
-510.24%		-8.805M
-1,732.89%		-14.973M
-70.05%		-7.367M
50.80%
Operating Margin
DRUG operating margin by date.DRUG operating margin by date.
N/AN/AN/AN/AN/A
EPS
YoY % growth
DRUG eps by date.DRUG eps by date.
N/AN/AN/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
DRUG Yearly EPS VS EstimatesDRUG Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
DRUG Yearly Revenue VS EstimatesDRUG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A